LCZ696 ameliorates doxorubicin-induced cardiomyocyte toxicity in rats

Doxorubicin (DOX)-based chemotherapy induces cardiotoxicity, which is considered the main bottleneck for its clinical application. In this study, we investigated the potential benefit of LCZ696, an angiotensin receptor–neprilysin inhibitor against DOX-induced cardiotoxicity in rats and H9c2 cells an...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyoshi, Toru, Nakamura, Kazufumi, Amioka, Naofumi, Hatipoglu, Omer F., Yonezawa, Tomoko, Saito, Yukihiro, Yoshida, Masashi, Akagi, Satoshi, Ito, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943022/
https://www.ncbi.nlm.nih.gov/pubmed/35322164
http://dx.doi.org/10.1038/s41598-022-09094-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943022/
https://www.ncbi.nlm.nih.gov/pubmed/35322164
http://dx.doi.org/10.1038/s41598-022-09094-z

Ejemplares similares